Clinical Trials Logo

Clinical Trial Summary

The primary objective of this clinical investigation is to investigate the safety of implantation of the human islet containing device Beta-Air in type 1 diabetic subjects. The secondary objective of this clinical investigation is to investigate if the transplantation of macro-encapsulated human islets within the Beta-Air device can provide improved glycaemic control in type 1 diabetes patients with reduced incidences of hypoglycaemic episodes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02064309
Study type Interventional
Source Uppsala University Hospital
Contact
Status Active, not recruiting
Phase Phase 1/Phase 2
Start date February 2014
Completion date May 2025